These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 33121980)

  • 1. Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized Trial.
    Pépin JL; Georgiev O; Tiholov R; Attali V; Verbraecken J; Buyse B; Partinen M; Fietze I; Belev G; Dokic D; Tamisier R; Lévy P; Lecomte I; Lecomte JM; Schwartz JC; Dauvilliers Y;
    Chest; 2021 Apr; 159(4):1598-1609. PubMed ID: 33121980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
    Dauvilliers Y; Verbraecken J; Partinen M; Hedner J; Saaresranta T; Georgiev O; Tiholov R; Lecomte I; Tamisier R; Lévy P; Scart-Gres C; Lecomte JM; Schwartz JC; Pépin JL;
    Am J Respir Crit Care Med; 2020 May; 201(9):1135-1145. PubMed ID: 31917607
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-Term Efficacy and Safety of Pitolisant for Residual Sleepiness Due to OSA.
    Pépin JL; Attali V; Caussé C; Verbraecken J; Hedner J; Lecomte I; Tamisier R; Lévy P; Lehert P; Dauvilliers Y
    Chest; 2024 Mar; 165(3):692-703. PubMed ID: 37979718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: A meta-analysis from randomized controlled trials.
    Wang J; Li X; Yang S; Wang T; Xu Z; Xu J; Gao H; Chen G
    Pharmacol Res; 2021 May; 167():105522. PubMed ID: 33667687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study.
    Dauvilliers Y; Craig SE; Bonsignore MR; Barbé F; Verbraecken J; Asin J; Georgiev O; Tiholov R; Caussé C; Lecomte JM; Schwartz JC; Lehert P; Randerath W; Pépin JL;
    J Sleep Res; 2024 Oct; ():e14373. PubMed ID: 39377364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment.
    Schweitzer PK; Mayer G; Rosenberg R; Malhotra A; Zammit GK; Gotfried M; Chandler P; Baladi M; Strohl KP
    Chest; 2021 Jul; 160(1):307-318. PubMed ID: 33631141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials.
    Meskill GJ; Davis CW; Zarycranski D; Doliba M; Schwartz JC; Dayno JM
    CNS Drugs; 2022 Jan; 36(1):61-69. PubMed ID: 34935103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related impact of illness associated with excessive daytime sleepiness in patients with obstructive sleep apnea.
    Grandner MA; Min JS; Saad R; Leary EB; Eldemir L; Hyman D
    Postgrad Med; 2023 Jun; 135(5):501-510. PubMed ID: 37129416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y; Takasaki Y; Yamashiro Y
    J Clin Sleep Med; 2013 Aug; 9(8):751-7. PubMed ID: 23946704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Outcomes in Adults with Coronary Artery Disease and Obstructive Sleep Apnea with versus without Excessive Daytime Sleepiness in the RICCADSA Cinical Trial.
    Eulenburg C; Celik Y; Redline S; Thunström E; Glantz H; Strollo PJ; Peker Y
    Ann Am Thorac Soc; 2023 Jul; 20(7):1048-1056. PubMed ID: 36800433
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Pitolisant 20 mg in Reducing Excessive Daytime Sleepiness and Fatigue in Patients with Obstructive Sleep Apnoea Syndrome: An Individual Patient Data Meta-analysis.
    Lehert P
    Clin Drug Investig; 2022 Jan; 42(1):65-74. PubMed ID: 34859394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Positive Airway Pressure Improves Quality of Life in Women with Obstructive Sleep Apnea. A Randomized Controlled Trial.
    Campos-Rodriguez F; Queipo-Corona C; Carmona-Bernal C; Jurado-Gamez B; Cordero-Guevara J; Reyes-Nuñez N; Troncoso-Acevedo F; Abad-Fernandez A; Teran-Santos J; Caballero-Rodriguez J; Martin-Romero M; Encabo-Motiño A; Sacristan-Bou L; Navarro-Esteva J; Somoza-Gonzalez M; Masa JF; Sanchez-Quiroga MA; Jara-Chinarro B; Orosa-Bertol B; Martinez-Garcia MA;
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1286-1294. PubMed ID: 27181196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world impact of continuous positive airway pressure on sleepiness in patients with obstructive sleep apnea in a national registry.
    Jennum P; Kjellberg J; Carls G; Ibsen R; Mettam S
    Sleep Med; 2024 Jun; 118():93-100. PubMed ID: 38657350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA.
    Antic NA; Catcheside P; Buchan C; Hensley M; Naughton MT; Rowland S; Williamson B; Windler S; McEvoy RD
    Sleep; 2011 Jan; 34(1):111-9. PubMed ID: 21203366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Persistent Excessive Daytime Sleepiness in OSA.
    Javaheri S; Javaheri S
    Chest; 2020 Aug; 158(2):776-786. PubMed ID: 32147246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Efficacy and Safety of Wakefulness-Promoting Agents for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea : A Systematic Review and Network Meta-analysis.
    Pitre T; Mah J; Roberts S; Desai K; Gu Y; Ryan C; Busse JW; Zeraatkar D
    Ann Intern Med; 2023 May; 176(5):676-684. PubMed ID: 37155992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.